Cargando…

Repurposing Antifungals for Host-Directed Antiviral Therapy?

Because of their epidemic and pandemic potential, emerging viruses are a major threat to global healthcare systems. While vaccination is in general a straightforward approach to prevent viral infections, immunization can also cause escape mutants that hide from immune cell and antibody detection. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schloer, Sebastian, Goretzko, Jonas, Rescher, Ursula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878022/ https://www.ncbi.nlm.nih.gov/pubmed/35215323 http://dx.doi.org/10.3390/ph15020212

Ejemplares similares

The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo
por: Schloer, Sebastian, et al.
Publicado: (2019)

Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection
por: Schloer, Sebastian, et al.
Publicado: (2020)

Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro
por: Kummer, Susann, et al.
Publicado: (2022)

Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine
por: Schloer, Sebastian, et al.
Publicado: (2020)

The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs
por: Schreiber, André, et al.
Publicado: (2022)

Annexins in Translational Research: Hidden Treasures to Be Found
por: Schloer, Sebastian, et al.
Publicado: (2018)

Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro
por: Schloer, Sebastian, et al.
Publicado: (2021)

Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro
por: Brunotte, Linda, et al.
Publicado: (2021)

Repurposing antifungal drugs for cancer therapy
por: Weng, Ningna, et al.
Publicado: (2022)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
por: Abdulaziz, Leena, et al.
Publicado: (2022)

Conserved cholesterol-related activities of Dispatched 1 drive Sonic hedgehog shedding from the cell membrane
por: Ehring, Kristina, et al.
Publicado: (2021)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection
por: Pires, David, et al.
Publicado: (2021)

Drug repurposing strategies in the development of potential antifungal agents
por: Zhang, Qian, et al.
Publicado: (2021)

Repurposing dyphylline as a pan-coronavirus antiviral therapy
por: Wang, Yining, et al.
Publicado: (2022)

Potential for the Repurposing of Adamantane Antivirals for COVID-19
por: Butterworth, Roger F.
Publicado: (2021)

Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19
por: Kumar, Pramod, et al.
Publicado: (2021)

Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity
por: Yip, Ashley Jia Wen, et al.
Publicado: (2022)

The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model
por: Schloer, Sebastian, et al.
Publicado: (2019)

Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19
por: Kumar, Santosh, et al.
Publicado: (2020)

Repurposing benzbromarone as antifolate to develop novel antifungal therapy for Candida albicans
por: Mujwar, Somdutt, et al.
Publicado: (2022)

Resurgence and Repurposing of Antifungal Azoles by Transition Metal Coordination for Drug Discovery
por: Cortat, Youri, et al.
Publicado: (2023)

Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis
por: Boland, Ralf, et al.
Publicado: (2022)

Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics
por: Prussia, Andrew, et al.
Publicado: (2011)

A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
por: Simonis, Alexander, et al.
Publicado: (2020)

Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial Cells
por: Krischuns, Tim, et al.
Publicado: (2018)

Repurposing of atorvastatin emulsomes as a topical antifungal agent
por: Eita, Alaa S., et al.
Publicado: (2022)

Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches
por: Cakir, Merve, et al.
Publicado: (2021)

Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus
por: Saiz, Juan-Carlos, et al.
Publicado: (2018)

Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
por: Jans, David A., et al.
Publicado: (2020)

Repurposing calcium channel blockers as antiviral drugs
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2020)

Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020)

Identification of antiviral antihistamines for COVID-19 repurposing
por: Reznikov, Leah R., et al.
Publicado: (2021)

Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections
por: Heemskerk, M. T., et al.
Publicado: (2021)

A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin
por: Zorofchian Moghadamtousi, Soheil, et al.
Publicado: (2014)

Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities
por: Matos, Aline da Rocha, et al.
Publicado: (2019)

Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms
por: Vanzolini, Tania, et al.
Publicado: (2022)

Antiviral, Antibacterial, Antifungal, and Antiparasitic Properties of Propolis: A Review
por: Zulhendri, Felix, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e32jcpg65dnehi8g9v3jfrssak